Pharmaceutical Executive October 17, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Access Insights 2024: Analyzing Drug Pricing and Reimbursement Data Amid a New Wave of CMS Price Requirements

The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.

Unlocking Pain Relief: The Role of Pharmacogenomics in Optimizing Opioid Therapy

Pharmacogenomic testing can help identify patients’ genetic profiles, revealing why certain drugs may be less effective or cause adverse effects.

Google Says Nuclear Is Key to Around-the-Clock Clean Power

Alphabet Inc.’s Google sees nuclear power as a key part of its strategy to get around-the-clock clean energy to operate artificial intelligence facilities, Michael Terrell, senior director of energy and climate, said on Bloomberg Television.

Rite Aid Partners...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article